Sybil Danby

Sybil Danby is the Global Commercial Leader for Viral Vectors at Cytiva. Before joining Cytiva she spent seven years in the cell and gene therapy CDMO space – most recently at the Center for Breakthrough Medicines (CBM) where she was one of the founding members of the leadership team. Prior to CBM, Sybil worked at Paragon Bioservices, now part of Catalent. During this time, she became very passionate about the potential of gene therapy and helping therapeutic developers overcome manufacturing challenges, enabling them to get products to patients.